Administration of GMI. ganglioside restores the dopamine content in striatum after chronic treatment with MPTP
- 1 September 1986
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 25 (9), 1075-1077
- https://doi.org/10.1016/0028-3908(86)90206-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro‐striatal neurons after different types of lesionActa Physiologica Scandinavica, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxinsJournal of Neuroscience Research, 1984
- Gangliosides minimize behavioral deficits and enhance structural repair after brain injuryJournal of Neuroscience Research, 1984
- Reduction of cerebral edema with GM1 gangliosideJournal of Neuroscience Research, 1983
- Epinephrine: A Potential Neurotransmitter in RetinaJournal of Neurochemistry, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous systemBrain Research, 1983
- The stimulating effect of ganglioside injections on the recovery of choline acetyltransferase and acetylcholinesterase activities in the hippocampus of the rat after septal lesionsNeuroscience, 1982